Hallmarks of response, resistance, and toxicity to immune checkpoint blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Published:2021-10 Issue:21 Volume:184 Page:5309-5337
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Morad Golnaz,Helmink Beth A.,Sharma Padmanee,Wargo Jennifer A.

Funder

NIH

Melanoma Research Alliance

Stand up to Cancer

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference243 articles.

1. Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease;Abu-Sbeih;Inflamm. Bowel Dis.,2020

2. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223);Andreae;J. Immunol.,2002

3. Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer;Arbour;J. Clin. Oncol.,2018

4. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade;Ayers;J. Clin. Invest.,2017

5. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens;Baixeras;J. Exp. Med.,1992

Cited by 827 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma;Immuno-Oncology and Technology;2024-12

2. Berberine sensitizes immune checkpoint blockade therapy in melanoma by NQO1 inhibition and ROS activation;International Immunopharmacology;2024-12

3. Collagen extracellular matrix promotes gastric cancer immune evasion by activating IL4I1-AHR signaling;Translational Oncology;2024-11

4. Immunosuppressive MDSC and Treg signatures predict prognosis and therapeutic response in glioma;International Immunopharmacology;2024-11

5. Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology;Current Pharmaceutical Biotechnology;2024-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3